Stepping down of asthma treatment 'worryingly infrequent' despite clinical and cost benefits

Asthma guidelines recommend stepping down of medication in stable patients, but new research shows this is not happening routinely in practice despite being safe and cost-effective.

by Chloe Harman
Stepping down of asthma treatment can reduce the risk of side-effects from long-term use of medication, particularly inhaled corticosteroids. | GETTY IMAGES
Stepping down of asthma treatment can reduce the risk of side-effects from long-term use of medication, particularly inhaled corticosteroids. | GETTY IMAGES

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package